Pulmonx (LUNG) EBITDA Margin (2019 - 2025)

Pulmonx (LUNG) reported EBITDA Margin of 66.76% for Q3 2025, down 14.0% year-over-year from 77.63% in Q3 2024, and down 8.07% quarter-over-quarter from 61.78% in Q2 2025.

Pulmonx (LUNG) EBITDA Margin (2019 - 2025) Analysis & Trends

Pulmonx (LUNG) has 7 years of EBITDA Margin data on file, last reported at 66.76% in Q3 2025.

  • EBITDA Margin for Q3 2025 came in at 66.76%, down 14.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 62.24% (up 903.0% YoY), and the FY2024 annual result was 67.93%, up 1911.0% from the prior year.
  • EBITDA Margin fell to 66.76% in Q3 2025 per LUNG's latest filing, from 61.78% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 57.21% in Q4 2024 and troughed at 149.25% in Q1 2022.
  • A 5-year average of 88.67% and a median of 84.4% in 2023 frame the typical range for EBITDA Margin.
  • On a YoY basis, EBITDA Margin climbed as much as 21958 bps in 2021 and fell as far as 5843 bps in 2021.
  • A 5-year view of EBITDA Margin shows it stood at 93.65% in 2021, then rose by 2 bps to 91.44% in 2022, then gained by 25 bps to 68.43% in 2023, then advanced by 16 bps to 57.21% in 2024, then fell by 17 bps to 66.76% in 2025.
  • Business Quant data shows LUNG's EBITDA Margin at 66.76% in Q3 2025, 61.78% in Q2 2025, and 63.71% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 Pulmonx 54.38 Mn -15.37 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -66.76%
Jun 30, 2025 -61.78%
Mar 31, 2025 -63.71%
Dec 31, 2024 -57.21%
Sep 30, 2024 -66.63%
Jun 30, 2024 -73.69%
Mar 31, 2024 -76.51%
Dec 31, 2023 -68.43%
Sep 30, 2023 -84.40%
Jun 30, 2023 -93.40%
Mar 31, 2023 -107.43%
Dec 31, 2022 -91.44%
Sep 30, 2022 -104.67%
Jun 30, 2022 -105.56%
Mar 31, 2022 -149.25%
Dec 31, 2021 -93.65%
Sep 30, 2021 -76.28%
Jun 30, 2021 -105.65%
Mar 31, 2021 -138.33%
Dec 31, 2020 -94.20%